Stocks / Biotech

IMVTBiotech

Immunovant, Inc.

$26.401d -4.0%5d -13.4%settled close · 2026-10-16

Mkt cap $5.4B (10/16)β 1.3452w $26–44Shares 203.5MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2019Emp. 362HQ Durham, NCimmunovant.com

The Wheel · put-selling

IMVT on the Wheel

IMVT is not in our put test yet; you can still add it to your Wheel and see its puts.

The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.

Add IMVT to your Wheel — free →

Decision support, not advice · questions put sellers ask us

Who’s talkingIdea Scout · free

Who’s talking about IMVT

No tracked investor commentary on IMVT yet — the corpus grows weekly.

Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →

Earnings

Next report: 30 Oct 2026

Confirmed date · consensus EPS -0.75. Reactions below are the next settled session over the prior close.

The options tapeThe Prime · members

Notable options days

Sessions in the last 120 where IMVT’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 16 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are member content.

Date	Close	RVOL	Δ$ flow ($M)	Call %	LEAPS %	+20 sess.
2026-10-16
2026-10-14
2026-10-12
2026-10-09
2026-10-08
2026-09-30
2026-09-28
2026-09-23
2026-09-01
2026-08-18
2026-08-17
2026-08-12
2026-07-06
2026-06-29
2026-06-12
2026-05-20

+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.

Follow IMVT and its tape leads The Brief, the free morning email, every trading day. Get The Brief — free →